Suppr超能文献

新型球囊引导单极导管用于心房颤动内部心脏复律和双腔起搏的初步经验。

Initial experience with a new balloon-guided single lead catheter for internal cardioversion of atrial fibrillation and dual chamber pacing.

作者信息

Plewan A, Valina C, Herrmann R, Alt E

机构信息

I Medizinische Klinik, Klinikum rechts der Isar, München, Germany.

出版信息

Pacing Clin Electrophysiol. 1999 Jan;22(1 Pt 2):228-32. doi: 10.1111/j.1540-8159.1999.tb00338.x.

Abstract

BACKGROUND

Based on the observation that internal cardioversion (IntCV) of atrial fibrillation is effective with electrodes in the right atrium and pulmonary artery, a new balloon-guided catheter and external defibrillation device with optional dual chamber pacing was evaluated.

METHODS

IntCV was attempted in 27 patients (age: 57 +/- 10 years, duration: 14 +/- 18 months, left atrial diameter 56 +/- 8 mm) using a new defibrillation device (Alert, EP MedSystems, Inc., NJ, USA) that allows the delivery of biphasic shocks (0.5-15 J, variable tilt), atrial and ventricular pacing, and online signal recording. Pacing and defibrillation shocks were applied via a 7.5 Fr balloon-guided catheter (EP MedSystems, Inc.). Pacing, sensing, and triggering were established through the proximal atrial array and an electrode ring between both defibrillation arrays and a single ventricular electrode ring. Catheters were inserted from the antecubital vein.

RESULTS

In 25 of 27 patients sinus rhythm was restored with a mean energy of 6.7 +/- 4.5 J. In five patients, atrial postshock pacing was required for bradycardia and atrial premature beats. The mean fluoroscopy time was 2.0 +/- 1.3 minutes.

CONCLUSION

The high success rate, ease of application, and backup dual chamber pacing suggest that this system is an alternative to established methods of cardioversion. In certain indications, such as failure of prior external cardioversion and situations in which a standard pulmonary balloon catheter is needed, this system would be advantageous.

摘要

背景

基于心房颤动的体内复律(IntCV)在右心房和肺动脉放置电极时有效的观察结果,对一种新型球囊引导导管及具备可选双腔起搏功能的体外除颤装置进行了评估。

方法

使用一种新型除颤装置(Alert,EP MedSystems公司,美国新泽西州)对27例患者(年龄:57±10岁,病程:14±18个月,左心房直径56±8mm)尝试进行体内复律。该装置可输送双相电击(0.5 - 15J,可变倾斜度)、心房和心室起搏以及在线信号记录。起搏和除颤电击通过一根7.5F球囊引导导管(EP MedSystems公司)施加。通过近端心房阵列以及两个除颤阵列之间的一个电极环和一个单心室电极环来建立起搏、感知和触发功能。导管从前臂静脉插入。

结果

27例患者中有25例恢复窦性心律,平均能量为6.7±4.5J。5例患者因心动过缓和房性早搏需要进行电击后心房起搏。平均透视时间为2.0±1.3分钟。

结论

高成功率、易于应用以及备用双腔起搏表明该系统是现有复律方法的一种替代方案。在某些适应症中,如先前体外复律失败以及需要标准肺动脉球囊导管的情况,该系统将具有优势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验